STX-478

News alerts, weekly reports and conference planners

Company:

Scorpion Therap

Drug class:

PI3Kα H1047R mutation inhibitor

Related drugs:

‹

›

PIK3CA mutation + ER positive	HER2 Negative Breast Cancer	PIK3CA mutation + ER positive	HER2 Negative Breast Cancer	STX-478 Sensitive: D – Preclinical STX-478 Sensitive : D	STX-478 Sensitive: D – Preclinical STX-478 Sensitive : D
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	palbociclib + STX-478 Sensitive: D – Preclinical palbociclib + STX-478 Sensitive : D	palbociclib + STX-478 Sensitive: D – Preclinical palbociclib + STX-478 Sensitive : D

Associations
(2)